Efficacy of topical cyclosporine A 2% in prevention of graft rejection in high-risk keratoplasty: a randomized controlled trial

被引：0
|
作者：
Rajesh Sinha
Vishal Jhanji
Kamna Verma
Namrata Sharma
Nihar R. Biswas
Rasik B. Vajpayee
机构：
[1] All India Institute of Medical Sciences,Rajendra Prasad Centre for Ophthalmic Sciences
[2] University of Melbourne,Centre for Eye Research Australia
[3] Royal Victorian Eye and Ear Hospital,Department of Ophthalmology and Visual Sciences
[4] The Chinese University of Hong Kong,Ocular Pharmacology, Rajendra Prasad Centre for Ophthalmic Sciences
[5] All India Institute of Medical Sciences,undefined
来源：
Graefe's Archive for Clinical and Experimental Ophthalmology | 2010年 / 248卷
关键词：
Keratoplasty; Cyclosporine; Corneal graft rejection; High-risk keratoplasty;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1167 / 1172
页数：5
相关论文
共 42 条
  • [1] Efficacy of topical cyclosporine A 2% in prevention of graft rejection in high-risk keratoplasty: a randomized controlled trial
    Sinha, Rajesh
    Jhanji, Vishal
    Verma, Kamna
    Sharma, Namrata
    Biswas, Nihar R.
    Vajpayee, Rasik B.
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2010, 248 (08) : 1167 - 1172
  • [2] Efficacy and Safety of Systemic Tacrolimus in High-Risk Penetrating Keratoplasty After Graft Failure With Systemic Cyclosporine
    Yamazoe, Kyoko
    Yamazoe, Katsuya
    Yamaguchi, Takefumi
    Omoto, Masahiro
    Shimazaki, Jun
    CORNEA, 2014, 33 (11) : 1157 - 1163
  • [3] Efficacy of topical cyclosporine-loaded nanocapsules on keratoplasty rejection in the rat
    Juberías, JR
    Calonge, M
    Gómez, S
    López, MI
    Calvo, P
    Herreras, JM
    Alonso, MJ
    CURRENT EYE RESEARCH, 1998, 17 (01) : 39 - 46
  • [4] Observation of topical tacrolimus on high-risk penetrating keratoplasty patients: a randomized clinical trial study
    Zhai, Li-Ying
    Zhang, Xiao-Rong
    Liu, Huan
    Ma, Yue
    Xu, Hong-Chang
    EYE, 2020, 34 (09) : 1600 - 1607
  • [5] Prevention of high risk corneal graft rejection using cyclosporine A (CsA) incorporated into a collagen matrix
    Mahlberg, K
    Uusitalo, RJ
    Oksala, O
    OCULAR IMMUNOLOGY AND INFLAMMATION, 1997, 5 (02) : 101 - 110
  • [6] Topical administration of tacrolimus and corticosteroids in tapering doses is effective in preventing immune rejection in high-risk keratoplasty: a 5-year follow-up study
    Qi, Xiaolin
    Wang, Lichao
    Zhang, Xiaoyu
    Liu, Min
    Gao, Hua
    BMC OPHTHALMOLOGY, 2022, 22 (01)
  • [7] Efficacy of tacrolimus capsules in patients undergoing high-risk keratoplasty
    Zhang, Xiaorong
    Yao, Jia
    Ma, Tengfei
    Chen, Haoyu
    Xu, Hengju
    Ye, Yinghui
    Zhai, Liying
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2024, 23 (01) : 157 - 165
  • [8] Immunosuppression with cyclosporine A and mycophenolate mofetil after penetrating high-risk keratoplasty:: A retrospective study
    Birnbaum, F
    Böhringer, D
    Sokolovska, Y
    Sundmacher, R
    Reinhard, T
    TRANSPLANTATION, 2005, 79 (08) : 964 - 968
  • [9] Efficacy of mycophenolate mofetil combined with topical 0.05% tacrolimus in high-risk keratoplasty: 1-year cohort study
    Zhang, Jin-Yu
    Yu, Kang
    Jiang, Xiu-Ying
    Liang, Jia-Xin
    Zhou, Shi-You
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2024, 17 (12) : 2229 - 2235
  • [10] Topical administration of tacrolimus and corticosteroids in tapering doses is effective in preventing immune rejection in high-risk keratoplasty: a 5-year follow-up study
    Xiaolin Qi
    Lichao Wang
    Xiaoyu Zhang
    Min Liu
    Hua Gao
    BMC Ophthalmology, 22
12345